Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study

Introduction: Beta thalassaemia is the most prevalent hereditary autosomal disorder, significantly impacting endocrine function during pubertal development. The pathology is rooted in the excessive deposition of iron in vital organs. If left untreated, this condition leads to serious morbidity and m...

Full description

Bibliographic Details
Main Authors: Rupali Modak, Amitava Pal, Shuvendu Das, Dilip Kumar Biswas
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-03-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/19165/64430_CE[Ra1]_F(SL)_Ref_PAT(SL)_QC(SHK_IS))_PF1(RI_DK_OM)_PFA(RI_KM)_PN(KM).pdf
_version_ 1797267236499488768
author Rupali Modak
Amitava Pal
Shuvendu Das
Dilip Kumar Biswas
author_facet Rupali Modak
Amitava Pal
Shuvendu Das
Dilip Kumar Biswas
author_sort Rupali Modak
collection DOAJ
description Introduction: Beta thalassaemia is the most prevalent hereditary autosomal disorder, significantly impacting endocrine function during pubertal development. The pathology is rooted in the excessive deposition of iron in vital organs. If left untreated, this condition leads to serious morbidity and mortality. Hypogonadism stands as the most common endocrine complication. Aim: To observe pubertal development in girls with thalassaemia and evaluate the adequacy of chelation therapy in such patients by measuring levels of Follicle Stimulating Hormone (FSH), Luteinising Hormone (LH), oestrogen, and serum ferritin. Materials and Methods: A quasi-experimental study was conducted at the Thalassaemia Clinic at the Department of Obstetrics and Gynaecology, Burdwan Medical College, Purba Bardhaman, West Bengal, India involving 300 diagnosed Beta Thalassaemia Major (BTM) (case) patients aged 13 to 17 years over a period of one and a half years (January 2020 to June 2021). The girls in the study groups were sequentially enrolled from the Outpatient Department of the Thalassaemia Clinic after meeting inclusion and exclusion criteria. Demographic data, anthropometric measurements, and Sexual Maturity Rating (SMR) were recorded. Hormonal assays of serum FSH, LH, oestrogen, and serum ferritin levels were conducted. Thalassaemic girls with serum ferritin levels exceeding 500 ng/mL received chelation therapy. Serum ferritin levels were measured at two-month intervals for up to six months, with reassessment of serum FSH, LH, oestrogen, and ferritin levels at the end of the six-month period. Statistical analysis was conducted using Statistical Package for Social Sciences (SPSS) version 27.0, Microsoft excel spreadsheet, and Epi Info 7. Results: A total of 190 (63.3%) of the thalassaemic girls were aged 13 to 15 years, with a mean Body Mass Index (BMI) of 22.5000±2.6100 kg/m2, and 74 of them (38.94%) experienced menarche in this age group. Out of 300 cases, 269 thalassaemic girls (89.6%) received chelation therapy, and 89 cases (33.09%) reached menarche after chelation therapy. A significant (p<0.0001) increase in mean LH and FSH levels was observed after chelation therapy. The mean ferritin level decreased from 3168.85 ng/mL to 2227.24 ng/mL following chelation therapy. Conclusion: Pubertal development failure is common in beta thalassaemic girls. Intervention in the form of adequate chelation therapy in girls with high serum ferritin levels yielded favourable outcomes, as evident from serum gonadotropin and oestrogen levels.
first_indexed 2024-04-25T01:13:23Z
format Article
id doaj.art-2f32455b153e428ebd686808b3d7605e
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-25T01:13:23Z
publishDate 2024-03-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-2f32455b153e428ebd686808b3d7605e2024-03-09T11:52:48ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2024-03-011803050910.7860/JCDR/2024/64430.19165Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental StudyRupali Modak0Amitava Pal1Shuvendu Das2Dilip Kumar Biswas3Assistant Professor, Department of Obstetrics and Gynaecology, RG Kar Medical College, Kolkata, West Bengal, India.Professor, Department of Obstetrics and Gynaecology, MJN Medical College, Coochbehar, West Bengal, India.Junior Resident, Department of Obstetrics and Gynaecology, Burdwan Medical College, Burdwan, West Bengal, India.Associate Professor, Department of Obstetrics and Gynaecology, Burdwan Medical College, Burdwan, West Bengal, India.Introduction: Beta thalassaemia is the most prevalent hereditary autosomal disorder, significantly impacting endocrine function during pubertal development. The pathology is rooted in the excessive deposition of iron in vital organs. If left untreated, this condition leads to serious morbidity and mortality. Hypogonadism stands as the most common endocrine complication. Aim: To observe pubertal development in girls with thalassaemia and evaluate the adequacy of chelation therapy in such patients by measuring levels of Follicle Stimulating Hormone (FSH), Luteinising Hormone (LH), oestrogen, and serum ferritin. Materials and Methods: A quasi-experimental study was conducted at the Thalassaemia Clinic at the Department of Obstetrics and Gynaecology, Burdwan Medical College, Purba Bardhaman, West Bengal, India involving 300 diagnosed Beta Thalassaemia Major (BTM) (case) patients aged 13 to 17 years over a period of one and a half years (January 2020 to June 2021). The girls in the study groups were sequentially enrolled from the Outpatient Department of the Thalassaemia Clinic after meeting inclusion and exclusion criteria. Demographic data, anthropometric measurements, and Sexual Maturity Rating (SMR) were recorded. Hormonal assays of serum FSH, LH, oestrogen, and serum ferritin levels were conducted. Thalassaemic girls with serum ferritin levels exceeding 500 ng/mL received chelation therapy. Serum ferritin levels were measured at two-month intervals for up to six months, with reassessment of serum FSH, LH, oestrogen, and ferritin levels at the end of the six-month period. Statistical analysis was conducted using Statistical Package for Social Sciences (SPSS) version 27.0, Microsoft excel spreadsheet, and Epi Info 7. Results: A total of 190 (63.3%) of the thalassaemic girls were aged 13 to 15 years, with a mean Body Mass Index (BMI) of 22.5000±2.6100 kg/m2, and 74 of them (38.94%) experienced menarche in this age group. Out of 300 cases, 269 thalassaemic girls (89.6%) received chelation therapy, and 89 cases (33.09%) reached menarche after chelation therapy. A significant (p<0.0001) increase in mean LH and FSH levels was observed after chelation therapy. The mean ferritin level decreased from 3168.85 ng/mL to 2227.24 ng/mL following chelation therapy. Conclusion: Pubertal development failure is common in beta thalassaemic girls. Intervention in the form of adequate chelation therapy in girls with high serum ferritin levels yielded favourable outcomes, as evident from serum gonadotropin and oestrogen levels.https://www.jcdr.net/articles/PDF/19165/64430_CE[Ra1]_F(SL)_Ref_PAT(SL)_QC(SHK_IS))_PF1(RI_DK_OM)_PFA(RI_KM)_PN(KM).pdfbeta thalassaemic patientsgonadotropinhormonal levelshypogonadismpubertysexual maturity rating
spellingShingle Rupali Modak
Amitava Pal
Shuvendu Das
Dilip Kumar Biswas
Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study
Journal of Clinical and Diagnostic Research
beta thalassaemic patients
gonadotropin
hormonal levels
hypogonadism
puberty
sexual maturity rating
title Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study
title_full Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study
title_fullStr Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study
title_full_unstemmed Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study
title_short Pubertal Development in Girls with Beta Thalassaemia and Assessment of the Adequacy of Chelation Therapy: A Quasi-experimental Study
title_sort pubertal development in girls with beta thalassaemia and assessment of the adequacy of chelation therapy a quasi experimental study
topic beta thalassaemic patients
gonadotropin
hormonal levels
hypogonadism
puberty
sexual maturity rating
url https://www.jcdr.net/articles/PDF/19165/64430_CE[Ra1]_F(SL)_Ref_PAT(SL)_QC(SHK_IS))_PF1(RI_DK_OM)_PFA(RI_KM)_PN(KM).pdf
work_keys_str_mv AT rupalimodak pubertaldevelopmentingirlswithbetathalassaemiaandassessmentoftheadequacyofchelationtherapyaquasiexperimentalstudy
AT amitavapal pubertaldevelopmentingirlswithbetathalassaemiaandassessmentoftheadequacyofchelationtherapyaquasiexperimentalstudy
AT shuvendudas pubertaldevelopmentingirlswithbetathalassaemiaandassessmentoftheadequacyofchelationtherapyaquasiexperimentalstudy
AT dilipkumarbiswas pubertaldevelopmentingirlswithbetathalassaemiaandassessmentoftheadequacyofchelationtherapyaquasiexperimentalstudy